AORTIC Hematology Oncology Research Group (AORTICHORG)2019-01-19T10:53:55+00:00

AORTIC Hematology Oncology Research Group (AORTICHORG)

The objectives of the African Organisation for Research and Training in Cancer (AORTIC) as enunciated at its foundation in 1982, which included promotion of research of cancer care challenges of African populations, are very relevant to the discipline of hematology/oncology, hence the creation in 2010 of the AORTIC Haematology Oncology Research Group (AORTICHORG) as a resource body within AORTIC organizing and co-ordinating research programs in the discipline of haematology and oncology. The group’s leadership includes a Chairperson, who presides at the group’s meetings, provides leadership in finding money for the group’s research activities and is responsible for providing feedback to funding bodies, and a Program Director/Secretary, who functions as principal scientific official of the group, receives and evaluates proposals for suitability for group activity and coordinates all research activities of the group. The group held its inaugural meeting at the 8th AORTIC Conference in Cairo, and has met ach of the two subsequent AORTIC conferences.

AORTICHORG’s first research proposal titled “Treatment Protocol For Acute Lymphoblastic Leukaemia In Nigerian Children And Young Adults” (Code Name: NIG-ALL-001) is led by Professor Muheez Durosinmi of the Department of Hematology, Obafemi Awolowo University, Ile-Ife, Nigeria. Its aim is to develop a cost-effective treatment protocol with acceptable toxicity for Nigerians living with acute lymphoblastic leukemia, a potentially curable disease. A total of 100 participants will be recruited and followed over a 5-year period at 5 Nigerian medical centers. A budget of about US$550,000, covering laboratory equipment, drugs, meetings and continued medical education of principal investigators, has been developed, and a submission for funding from the Tertiary Education Fund (TETFUND) of the Nigerian Government has been made. It is hoped that when the group develops its research capabilities, it would be able to expand future studies to other African centers.